ON123300
National Institutes of Health
Papers overview
Semantic Scholar uses AI to extract papers important to this topic.
Dear Editor, Activating mutations in KRAS have been found in nearly 50% of colorectal cancers (CRCs), and patients with KRAS…
Introduction: This study describes the development of a novel dual specificity kinase inhibitor, ON 123300, which exhibits potent…
Proceedings: AACR Annual Meeting 2014; April 5-9, 2014; San Diego, CA
Multiple Myeloma (MM) is an incurable malignancy of plasma…